---
schema_version: "secwatch.filing_event.v1"
accession: "0001372514-25-000068"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:53:22.897216+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals furnishes updated investor presentation for H.C. Wainwright conference

## Summary
- Filed 8-K on August 13, 2025 to disclose updated investor presentation (Exhibit 99.1).
- Presentation prepared for H.C. Wainwright 5th Annual Ophthalmology Virtual Conference.
- Company CFO Melissa Tosca signed the report as principal financial officer.
- Data presented under Item 7.01 Regulation FD and not deemed filed for Exchange Act purposes.

## SEC filing metadata
- accession: 0001372514-25-000068
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/0001372514-25-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000137251425000068/kprx-20250813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001372514-25-000068
- JSON: https://secwatch.observer/filing/0001372514-25-000068.json
- Plain text: https://secwatch.observer/filing/0001372514-25-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.